Japan vs Luxembourg: Cause of death, by non-communicable diseases, ages 15-59
Japan
74.7%
in 2021
Luxembourg
74.8%
in 2021
Japan rank
26th
Luxembourg rank
25th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Japan
- Luxembourg
How they compare
Luxembourg currently reports 74.8% against 74.7% in Japan, a difference of 0.1%.
Across all 6 years both countries report, Luxembourg has been ahead every year.
Japan ranks 26th and Luxembourg ranks 25th of 185 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.6% | 73.2% | 2.7% | Luxembourg |
| 2010s | 73.4% | 77.3% | 3.9% | Luxembourg |
| 2020s | 75.3% | 75.3% | 0.1% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Japan or Luxembourg?
- Luxembourg, at 74.8% against 74.7% in Japan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Japan and Luxembourg?
- 0.1%, with Luxembourg ahead.
- How many years of comparable data are there for Japan and Luxembourg?
- 6 years are reported by both, from 2000 to 2021.
- How do Japan and Luxembourg rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Japan ranks 26th and Luxembourg ranks 25th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.